Angiotensin converting enzyme inhibitors: should they be used early post myocardial infarction?
Pitt
Bertram
B
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D015912:Thrombolytic Therapy; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator